ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Nanoformulation of peppermint (Mentha Piperita L.) and rosemary (Rosmarinus officinalis L.) essential oils: Antibacterial effects.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Essential oils are known for their natural antibacterial properties; however, their clinical and industrial applications are often limited by poor water solubility and low bioavailability. Nanoformulation techniques such as nanoemulsions, nanocomposites, nanocapsules, and liposomes have emerged as effective strategies to overcome these limitations, enhancing the stability, solubility, and antimicrobial activity of essential oils. This study investigates the antibacterial activity of peppermint (Mentha piperita L.) and rosemary (Rosmarinus officinalis L.) essential oils, delivered via various nanoformulations, against Staphylococcus epidermidis and Escherichia coli. Essential oils were extracted using a Clevenger apparatus and analyzed by GC-MS. Formulations were prepared, and particle sizes measured via electron microscopy. Antibacterial activity was also evaluated through antibiogram tests. All experiments were conducted in triplicate. The main components identified were methyl cyclohexanol (35.90%) in peppermint and camphor (23.22%) in rosemary essential oils. Particle sizes for peppermint nanoemulsions, nanocomposites, nanocapsules, and nanoliposomes were 3.34, 27.14, 19.25, and 19.01 nm, respectively; for rosemary were 2.69, 71.07, 35.02, and 25.38 nm. Both pure essential oils and their nanoformulations showed effective antimicrobial activity against Gram-positive and Gram-negative bacteria, with nanoformulations exhibiting stronger effects. Gram-positive bacteria were more susceptible overall. Notably, nanoparticles and nanoliposomes had greater inhibitory effects than pure essential oils, and nanoemulsions demonstrated even higher antimicrobial activity than nanoliposomes. These results suggest that the essential oils of peppermint and rosemary, as well as their nanoformulations, may exhibit enhanced potency and could be effectively used as integrated agents against bacterial pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.